- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
Nasdaq
Wall Street JournalEN
C
CPRX
Catalyst Pharmaceuticals Inc
24.30
-0.12-0.49%After Hours: 24.25 -0.05 -0.21%19:49 02/20 EST
OPEN/PREV CLOSE24.40/24.42
TODAY RANGE23.87-24.62
VOL1.27M
MARKET CAP2.99B
52 WEEK RANGE19.05-26.58
AVG VOL (3M)1.24M
% TURNOVER1.04%
TURNOVER--
P/E (TTM)14.18
% RANGE3.01%
EPS(TTM)1.714
P/E(FORWARD)15.00
P/B3.255
BVPS7.47
DIVIDEND--
P/S5.97
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP2.80B
SHARES OUTSTANDING122.91M
NEXT EARNINGS02/24-03/02
FREE FLOAT115.36M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·2d ago
Catalyst Pharmaceuticals: Clear Path Forward For Growth In 2 FDA-Approved Drugs
Dow Jones·01/23 21:34
Catalyst Pharmaceuticals Inc. Stock Falls 3.6%, Underperforms Peers
Benzinga·01/14 17:26
Jim Cramer: Crane Is A 'Good' Company, Recommends Holding This Tech Stock
TipRanks·01/12 13:38
Catalyst Pharma Highlights Growth Strategy at J.P. Morgan Conference
Dow Jones·12/30/2025 21:33
Catalyst Pharmaceuticals Inc. Stock Sheds 3.2%, Underperforms Peers
NASDAQ·12/23/2025 14:50
Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Momentum Stock
NASDAQ·12/22/2025 16:21
First Week of February 2026 Options Trading For Catalyst Pharmaceuticals (CPRX)
TipRanks·12/17/2025 02:02
Catalyst Pharma Director Makes a Bold Move with Stock Sale!
Reuters·12/15/2025 13:03
Catalyst Pharmaceuticals to Present at J.P. Morgan Healthcare Conference
Seeking Alpha·12/14/2025 19:00
Healthcare Dashboard For December And Focus On PJP
NASDAQ·12/04/2025 14:15
Collegium Pharmaceutical, Inc. (COLL) Hits Fresh High: Is There Still Room to Run?
Seeking Alpha·12/03/2025 22:37
Catalyst: Firdapse Cliff Deferred, But Capital Allocation Still An Issue (Upgrade)
Same Industry
Name/Symbol
Change%
Price